Skip to main content

Radicava ORS Disease Interactions

There are 2 disease interactions with Radicava ORS (edaravone).

Moderate

Edaravone (applies to Radicava ORS) asthma

Moderate Potential Hazard, Moderate plausibility.

Edaravone contains sodium bisulfite, a sulfite that may cause allergic reactions, including life-threatening or less severe asthmatic episodes in susceptible people. Sulfite sensitivity occurs more frequently in asthmatic than non-asthmatic people. Patients should be advised to seek immediate medical care if they experience signs and symptoms of asthma.

References (1)
  1. (2022) "Product Information. Radicava ORS (edaravone)." Mitsubishi Tanabe Pharma America (formerly MT Pharma America), SUPPL-12
Moderate

Edaravone (applies to Radicava ORS) renal impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction

Edaravone has not been studied in patients with severe renal impairment. No dosage modifications are required in patients with mild or moderate renal impairment.

References (1)
  1. (2022) "Product Information. Radicava ORS (edaravone)." Mitsubishi Tanabe Pharma America (formerly MT Pharma America), SUPPL-12

Switch to consumer interaction data

Radicava ORS drug interactions

There are 19 drug interactions with Radicava ORS (edaravone).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer